FDA Adverse Event Injury Summary report: N

GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS

MDR report key: 15839415 · Received November 21, 2022

Report

Report Number
3013164176-2022-01546
Event Type
Injury
Date Received
November 21, 2022
Date of Event
October 23, 2022
Report Date
December 6, 2022
Manufacturer
W. L. GORE & ASSOCIATES, INC.
Product Code
MIH
UDI-DI
00733132635306
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDICATIONS, COMORBIDITIES, AND WEIGHT WERE NOT PROVIDED BY THE TREATING FACILITY. AS GORE WAS UNABLE TO DETERMINE WHICH DEVICE(S) CAUSED OR CONTRIBUTED TO THE EVENT IF ANY; ADDITIONAL DEVICE(S) IMPLANTED RELATED TO THIS EVENT INCLUDE THE FOLLOWING: 11183-2: BRAND: GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; PRODUCT NAME: STENT GRAFT ILIAC BRANCH COMPONENT; CATALOG NUMBER: CEB231410A; LOT/SN: (B)(4); UDI: (B)(4). 11183-7: BRAND: GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; PRODUCT NAME: STENT GRAFT INTERNAL ILIAC COMPONENT; CATALOG NUMBER: HGB161407A; LOT/SN: (B)(4); UDI: (B)(4). COMMUNICATION/INTERVIEWS- ADDITIONAL INFORMATION IN REGARD TO THE EVENT OF THE CASE WAS REQUESTED. RESULTS PENDING COMPLETION OF INVESTIGATION: MANUFACTURING EVALUATION RESULTS WILL BE PROVIDED ONCE THEY ARE COMPLETED. DEVICE NOT ACCESSIBLE FOR TESTING: AS REPORTED THE DEVICES ARE NOT ACCESSIBLE FOR TESTING. IT IS NOT CONFIRMED IF ALL IMPLANTED DEVICES WERE EXPLANTED OR JUST A PORTION OF THEM. THOSE THAT WERE EXPLANTED WERE NOT RETURNED FOR INVESTIGATION. W. L. GORE & ASSOCIATES, INC. (GORE) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY GORE, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. BLANK FIELDS PRESENT ON THIS REPORT INCLUDE REQUIRED FIELDS AND FIELDS DETERMINED TO BE NOT APPLICABLE. BLANK REQUIRED FIELDS INDICATE THAT THE INFORMATION WAS NOT PROVIDED, WAS DEEMED UNAVAILABLE OR WAS NOT APPLICABLE. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, GORE, OR ITS ASSOCIATES THAT THE DEVICE, GORE OR ITS ASSOCIATES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE A LEGAL ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY DEFECTS OR HAS MALFUNCTIONED, AS DEFINED FROM A LEGAL STANDPOINT. THESE WORDS ARE INCLUDED IN THE REPORT AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.

Additional Manufacturer Narrative · 0

H6: G CODE UPDATED FROM G07001 TO G04122.

Additional Manufacturer Narrative · 0

H6: CODE C19, NO DEVICE PROBLEM FOUND: A REVIEW OF MANUFACTURING RECORDS VERIFIED THAT THE LOT INVOLVED IN THIS EVENT MET ALL PRE-RELEASE SPECIFICATIONS. G3/G4. DATE RECEIVED BY MANUFACTURER UPDATED TO 29-NOV-2022, AS THE MANUFACTURING RECORD REVIEWS WERE COMPLETED ON THIS DATE. H6: G CODE UPDATED FROM G04122 STENT TO G07001. H6: CODE C21, RESULTS PENDING COMPLETION OF INVESTIGATION WAS REPLACED WITH FINDINGS. H6: CODE D16, CONCLUSION NOT YET AVAILABLE REPLACED WITH CONCLUSIONS.

Description of Event or Problem · 0

ON (B)(6) 2019, THE PATIENT WAS IMPLANTED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES AND BILATERAL GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESES FOR TREATMENT OF AN ANEURYSM. CASE PLANNING FROM (B)(6) 2019 WAS PROVIDED FOR CONSIDERATION. AS REPORTED, ON (B)(6) 2022, THE PATIENT PRESENTED TO THE EMERGENCY ROOM WITH A SPINE ABSCESS. COMPUTED TOMOGRAPHY (CT) WAS PERFORMED AND SHOWED PATENCY ON ALL COMPONENTS EXCEPT THE BRANCH OF THE LEFT INTERNAL ILIAC. AS REPORTED A SAMPLE OF THE ABSCESS WAS TAKEN. ON (B)(6) 2022, THE PATIENT PRESENTED WITH RETROPERITONEAL BLEED AND AIR IN THE ANEURYSM SAC. AS REPORTED, THE PHYSICIAN BELIEVED THERE TO BE A RUPTURE COMING FROM THE RIGHT LIMB BASED ON HOW THE RETROPERITONEAL BLEED PRESENTED WITHIN THE CT AND PROCEEDED WITH OPEN REPAIR. REPORTEDLY, UPON OPEN REPAIR, IT WAS OBSERVED THAT THE ANEURYSM SAC WAS FULL OF PUSS. AS REPORTED, THE RETROPERITONEAL BLEED WAS NOT DUE TO THE ANEURYSM RUPTURE, BUT THE SPINAL BIOPSY THAT HAD STUCK THE ANEURYSM SAC. AS REPORTED, THE BACK SIDE OF THE ANEURYSM SAC HAD ERODED INTO THE BOWEL. AS REPORTED, THE GRAFT WAS EXPLANTED. AS REPORTED, THE PATIENT TOLERATED THE PROCEDURE AND WAS DOING WELL AS OF (B)(6) 2022. CONFIRMATION OF DEVICE SERIAL NUMBERS THAT WERE IMPLANTED IN THE PATIENT WERE REQUESTED AND OBTAINED. HOWEVER IT WAS NOT CONFIRMED WHICH ENDOPROSTHESES OR IF ALL OF THE IMPLANTED ENDOPROSTHESES WERE EXPLANTED FROM THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2688047 GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES, INC. CEB231410A 00733132635306

Patients

Seq Age Sex Outcome Treatment
1 77 YR Female Life Threatening| R SEE H10/H11